您的位置:山东大学 -> 科技期刊社 -> 《山东大学学报(医学版)》

山东大学学报 (医学版) ›› 2020, Vol. 58 ›› Issue (4): 118-120.doi: 10.6040/j.issn.1671-7554.0.2019.1126

• 病例报道 • 上一篇    

常染色体显性多囊肾病伴原发性醛固酮增多症1例

许琴,高梅,王海民,曹凌瑕,孙成林   

  1. 吉林大学第一医院内分泌代谢科, 吉林 长春 130021
  • 发布日期:2022-09-27
  • 通讯作者: 孙成林. E-mail:clsun213@163.com

  • Published:2022-09-27

关键词: 常染色体显性多囊肾病, 原发性醛固酮增多症, 高血压, 低钾血症

中图分类号: 

  • R586.2
[1] 徐德超,马熠熠,梅长林.托伐普坦治疗快速进展型常染色体显性多囊肾病的临床实践指南解读[J].中华肾脏病杂志,2019,35(5):387-392. XU Dechao, MA Yiyi, MEI Changlin. Interpretation of the clinical practice guideline for treatment of rapidly progressive autosomal dominant polycystic kidney disease with tolvaptan[J]. Chinese Journal of Nephrology, 2019, 35(5):387-392.
[2] Harris PC. 2008 Homer W. Smith Award:insights into the patho genesis of polycystic kidney disease from gene discovery [J]. J Am Soc Nephrol, 2009, 20(6):1188-1198.
[3] Nash DA Jr. Hypertension in polycystic kidney disease without renal failure[J].Arch Intern Med,1977,137(11):1571-1575.
[4] Chapman AB, Johnson A, Gabow PA, et al. The renin-angiotensin-aldosterone system and autosomal dominant polycystic kidney disease[J]. N Engl J Med,1990,323(16):1091-1096.
[5] Torres VE, Donovan KA, Scicli G, et al. Synthesis of renin by tubulocystic epithelium in autosomal-dominant polycystic kidney disease[J]. Kidney Int,1992, 42(2):364-373.
[6] Loghman-Adham M, Soto CE, Inagami T, et al. The intrarenal renin-angiotensin system in autosomal dominant polycystic kidney disease[J]. Am J Physiol Renal Physiol, 2004, 287(4):775-788.
[7] Ramanathan G, Elumalai R, Periyasamy S, et al. Role of renin-angiotensin-aldosterone system gene polymorphisms and hypertension-induced end-stage renal disease in autosomal dominant polycystic kidney disease[J]. Iran J Kidney Dis, 2014, 8(4):265-277.
[8] Hirai H, Kanno M, Watanabe T, et al. Kidney dysfunction following adrenalectomy in autosomal dominant polycystic kidney disease complicated with primary aldosteronism: A case report[J]. Exp Ther Med, 2017,14(2):1235-1240.
[9] Conn JW,Louis LH. Primary aldosteronism,a new clinical entity [J]. Ann Intern Med,1956,44(1):1-15.
[10] Funder JW, Carey RM, Mantero F, et al. the management of primary aldosteronism: case detection, diagnosis, and treatment: an endocrine society clinical practice guideline[J]. J Clin Endocrinol Metab, 2016, 101(5):1889-1916.
[11] Sang X, Jiang Y, Wang W, et al. Prevalence of and risk factors for primary aldosteronism among patients with resistant hypertension in China[J]. J Hypertens, 2013, 31(7):1465-1471.
[12] 蒋怡然,王卫庆. 原发性醛固酮增多症在中国的诊治现状及研究进展[J]. 中华内分泌代谢杂志,2018,34(9):717-720. JIANG Yiran, WANG Weiqing. Diagnosis, treatment and progress of primary aldosteronism in China[J]. Chinese Journal of Endocrinology and Metabolism, 2018, 34(9):717-720.
[13] 赖凤华,曹筱佩,林慧美,等.两种血浆肾素、醛固酮检测方法对原发性醛固酮增多症筛查效率的评价[J]. 中华高血压杂志,2015,23(2):150-153. LAI Fenghua, CAO Xiaopei, LIN Huimei, et al. Comparison of plasma renin and aldosterone measured by radioimmunoassay and chemiluminescence immunoassay in screening primary aldosteronism[J]. Chinese Journal of Hypertension, 2015, 23(2):150-153.
[14] Saeki S, Ogihara T, Masugi F, et al. A case of primary aldosteronism with polycystic kidney disease[J]. Nihon Naika Gakkai Zasshi,1986,75(1):28-32.
[15] Franchini M, Mannucci PM. The history of hemophilia[J]. Semin Thromb Hemost, 2014, 40(5):571-576.
[16] 中华医学会血液学分会血栓与止血学组, 中国血友病协作组. 血友病诊断与治疗中国专家共识(2017年版)[J]. 中华血液学杂志, 2016, 37(5):364-370. Thrombosis and Hemostasis Group, Hematology Societ. Consensus of Chinese expert on the diagnosis and treatment of hemophilia(version 2017)[J]. Chinese Journal of Hematology, 2016, 37(5):364-370.
[1] 吴逸南 葛志明 李方 贺红 姜虹 张运. 自发性高血压大鼠肾脏血管紧张素转换酶2的表达[J]. 山东大学学报(医学版), 2209, 47(6): 5-.
[2] 邬雨洁,张明泉,纪永利,赵璐,王越,陈沙沙. 寒痉汤及其拆方对寒凝证高血压大鼠血清炎症因子、血管内皮功能及纤维化的影响[J]. 山东大学学报 (医学版), 2022, 60(6): 10-18.
[3] 宋钰峰,宁豪,姚志刚,吴海虎,刘非凡,吕家驹. 肾上腺海绵状血管瘤临床及影像特征[J]. 山东大学学报 (医学版), 2022, 60(2): 37-42.
[4] 吕岩红,张志勉. 2 809名体检人群中高血压与幽门螺杆菌感染的关联性[J]. 山东大学学报 (医学版), 2022, 60(2): 43-47.
[5] 吴瑕,王文红. ATP6V0A4基因纯合内缺失致远端肾小管酸中毒1例并12年随访分析[J]. 山东大学学报 (医学版), 2021, 59(11): 67-71.
[6] 付依林,郭田,宫颖,姚振宇,管庆波,徐潮,周新丽,张海清,郑冬梅,刘鲁娜,赵家军. 554例内分泌科住院患者低钾血症的病因和临床特点的回顾性分析:来自单中心的研究[J]. 山东大学学报 (医学版), 2021, 59(10): 39-46.
[7] 贾明旺,廖广园,熊明媚,徐文婷,王银玲,王懿春. 84例妊娠合并肺高血压患者预后的临床分析[J]. 山东大学学报 (医学版), 2021, 59(1): 34-39.
[8] 国雪杰,杨孝荣,桑少伟,刘兵艳,吕明. 济南市平阴县农村成年居民高血压知晓现状及影响因素[J]. 山东大学学报 (医学版), 2019, 57(12): 103-109.
[9] 王倩,徐凌忠,朱静,张娇,谢苏,于子航. 山东省农村老年高血压患者心理健康状况及其影响因素[J]. 山东大学学报 (医学版), 2019, 57(1): 92-100.
[10] 薛莉,胡文琦,魏然,张安然,林君芬,马伟. 2011~2013年高温热浪对苍南县高血压门诊就诊量的影响[J]. 山东大学学报 (医学版), 2018, 56(8): 63-69.
[11] 于涛,刘焕乐,冯新,徐付印,陈亚飞,薛付忠,张成琪. 基于健康管理队列的高血压风险预测模型[J]. 山东大学学报(医学版), 2017, 55(6): 61-65.
[12] 严芳英,单晓兰,李静媛,张杰,闫雪芳,杨奕,卜培莉. 吡格列酮通过调控Sirt3改善高血压引起的心肌纤维化机制[J]. 山东大学学报(医学版), 2017, 55(5): 13-18.
[13] 李睿,马伟红,任满意,赵萌萌,姜珊,巨媛媛,郭颖,孙昭辉,隋树建. TWEAK与原发性高血压患者心脏重塑的相关性[J]. 山东大学学报(医学版), 2017, 55(5): 49-55.
[14] 王维军,周宁全,王超. CT定位微创徒手穿刺软通道技术治疗中等量高血压脑出血68例[J]. 山东大学学报(医学版), 2017, 55(5): 61-65.
[15] 张华,庄霞,刘振东,刁玉涛,杜佳晨,崔谊. 磁共振弥散张量成像技术评价高血压对年轻成年人脑白质损伤[J]. 山东大学学报(医学版), 2017, 55(5): 56-60.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!